Attendees during Importance of Overall Survival in Assessing Risk/Benefit: The PARP and PI3K Inhibitor Stories
-
AACR Annual Meeting 2021: Discovery Science Driving Clinical Breakthroughs
AACR President Antoni Ribas, MD, PhD, FAACR, says that the Annual Meeting will bring together cancer care and research professionals to educate, collaborate, and celebrate their shared mission.